167556-64-1 Usage
Uses
Used in Organic Synthesis:
2-Methyl-5-(tributylstannyl)pyridine is used as a chemical intermediate for the formation of carbon-carbon bonds in organic synthesis. Its tributyltin group allows for a range of reactions, facilitating the creation of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Methyl-5-(tributylstannyl)pyridine is used as a building block for the development of new drugs. Its unique structure and reactivity contribute to the synthesis of bioactive compounds with potential therapeutic applications.
Used in Chemical Research:
2-Methyl-5-(tributylstannyl)pyridine is utilized as a research tool in chemical laboratories to study the properties and reactions of organotin compounds. Understanding its behavior in various chemical processes can lead to the discovery of new synthetic pathways and applications.
Used in Material Science:
In the field of material science, 2-Methyl-5-(tributylstannyl)pyridine is employed in the synthesis of advanced materials with specific properties. Its ability to form carbon-carbon bonds can contribute to the development of new polymers, coatings, and other materials with unique characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 167556-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,5,5 and 6 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 167556-64:
(8*1)+(7*6)+(6*7)+(5*5)+(4*5)+(3*6)+(2*6)+(1*4)=171
171 % 10 = 1
So 167556-64-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N.3C4H9.Sn/c1-6-4-2-3-5-7-6;3*1-3-4-2;/h2,4-5H,1H3;3*1,3-4H2,2H3;/rC18H33NSn/c1-5-8-13-20(14-9-6-2,15-10-7-3)18-12-11-17(4)19-16-18/h11-12,16H,5-10,13-15H2,1-4H3
167556-64-1Relevant academic research and scientific papers
HIV protease inhibiting compounds
-
Page/Page column 136, (2010/02/12)
A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
